Remove authors pharmaceutical-technology-editors
article thumbnail

AI is having a productive time in pharma and healthcare

pharmaphorum

It could even be, as consultants GlobalData predicted back in January, this year’s most disruptive technology across the pharmaceutical industry, though if this promise is to be realised there is much more work to be done about its ethical implications. About the author. FDA approvals. NHS use continues to grow.

131
131
article thumbnail

No cooling off for pharma digital transformation in 2021

pharmaphorum

COVID-19 has already proved to be a digital accelerant for the pharmaceutical industry, sparking new ideas into life and lighting a fire underneath existing plans that had, in retrospect, yet to burn brightly. The healthcare industry is at an inflection point,” agrees Novartis’ Elizabeth Theophille. Pharma’s digital moment. years and $2.5

109
109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GenAI in pharma: where are we today?

European Pharmaceutical Review

A recent survey from the Pistoia Alliance revealed that AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years. Levy is a leading life sciences expert who has published multiple articles on drug development and technology trends.

article thumbnail

Do skills gaps and the COVID brain drain threaten digital transformation?

pharmaphorum

In a report published last month, the Association of the British Pharmaceutical Industry (ABPI) noted significant skills gaps in several areas. However, it also notes that desirable skill sets are evolving as quickly as the technology itself, and that the crossover between digital skills and scientific experience was “of particular concern”.

article thumbnail

Health tech and digital transformation lessons from the NHS

pharmaphorum

Just as it did across the pharmaceutical industry , COVID’s medical imperative swept aside any lingering doubts and delays to greater use of technology, kick-starting a major digital transformation of healthcare. GPs want an informed choice over the technology that they implement. The NHS’ digital future.

Vaccines 144
article thumbnail

How should cleaning validation sampling locations be chosen?

European Pharmaceutical Review

The article, published in the Journal of Validation Technology ( JVT ), presents the case study of a company undergoing an investigation and developing a strategy for identifying worst-case sampling locations on equipment, after a regulatory auditor asked for such a rationale and no written documentation could be provided.

article thumbnail

5 ways digital health, and digital pharma, changed in 2020

pharmaphorum

COVID-19 brought rapid, deep and likely lasting changes to healthcare and the pharmaceutical sector, as both scrambled to respond to unprecedented demands. The creation of the FDA’s Digital Health Center for Excellence in September marked a major step forward for the US regulator’s approach to new technology. About the author.